KGCA Gastric Cancer Guidelines 2022

Surgical GJ and ES are palliative treatments for GOO caused by unresectable gastric cancer. GJ is the standard palliative treatment for GOO and adequately relieves symptoms of GOO. However, early major complications and procedure-related mortality have been reported to be substantial. ES is increasingly being performed for malignant GOO. With a shorter procedure time, faster resumption of oral intake, and shorter duration of hospital stay than GJ, ES presents an effective and less invasive therapeutic option for the palliative treatment of GOO . Nevertheless, compared with GJ, a higher rate of complications, reintervention, and recurrent obstruction has also been reported.

Our results suggest that ES may be associated with more favorable results in patients who are poor surgical candidates with relatively short life expectancy and those who place a high value on resumption of oral diet and being discharged early, while GJ is preferable in patients with more prolonged prognosis and good performance status.